Abstract
Charcot neuroarthropathy is a common complication of peripheral neuropathy. Today, it is most commonly seen in patients with diabetes mellitus but was classically seen in patients with tabes dorsalis. It is thought to be due to a loss of protective sensation in the foot and ankle. Commonly misdiagnosed as infection, it is important to recognize the signs and symptoms of Charcot joints early so appropriate treatment can be initiated. Unrecognized Charcot joints can lead to progressive deformity and loss of mobility due to the increased risk of infection and amputation. The goals of treatment are to maintain alignment and stability through the evolution of the Charcot process in order to preserve patient mobility and prevent complications. Treatment options depend on the stage of the Charcot joint and the joints involved. Conservative treatment usually begins with modified weight bearing and total contact casting, but may progress to surgical intervention if conservative measures fail.
Access provided by CONRICYT-eBooks. Download chapter PDF
Similar content being viewed by others
Keywords
Background
-
Definition: A destructive, non-infective process of bones and joints that occurs due to the loss of protective sensation that occurs with peripheral neuropathy
-
Associations:
-
In the USA, most commonly associated with longstanding diabetes mellitus
-
Other associations include leprosy, tabes dorsalis, Charcot-Marie-Tooth, and alcohol abuse
-
-
Patient burden: Commonly painless but associated with progressive deformity of the foot and joint instability leading to altered gait mechanics and load bearing
-
Increased risk for pressure ulcers, infections, and ultimately amputations
-
Increased patient morbidity and decreased quality of life
-
Pathophysiology
It is not clearly understood but there are currently two theories which both hinge on the idea that the patient’s continued weight bearing in the face of injury leads to progressive destruction of the involved bones and joints [2–4].
Neurotraumatic Destruction
-
Joint destruction, fractures, and foot collapse occur due to cumulative mechanical trauma.
-
Can be major, minor, or microtrauma that the patient does not recognize due to lack of protective sensation in the foot.
-
Continued activity and weight bearing propagate the destruction and inhibit the healing process.
Neurovascular Destruction
-
Trauma or another trigger causes a state of hyperemia due to vasomotor autoneuropathy.
-
Dysregulation of blood flow leads to cytokine mediated bone resorption and ligamentous weakening.
-
Leads to bone breakdown and joint dislocation with progressive deformity due to continued high levels of pro-inflammatory cytokines.
Presentation and Evaluation
Most present with a red, warm, swollen foot with a history of diabetes and no recollection of injury.
-
Patients often present initially with a red, hot, swollen foot that is commonly misdiagnosed as cellulitis or osteomyelitis.
-
Key finding in differentiating Charcot is that the erythema and swelling resolves with elevation of the limb. Osteomyelitis, cellulitis, or other infection will remain erythematous despite elevation.
-
Will have evidence of peripheral neuropathy with decreased sensation with monofilament testing.
-
May have concomitant vascular disease and workup with ankle-brachial indices (ABI’s) and toe pressures may be warranted.
-
Radiographs may show erosive changes and even new bone formation but lack the surrounding osteopenia associated with osteomyelitis. Joint subluxations and dislocations are commonly seen in advanced cases.
-
Bone biopsy may be useful in differentiating between Charcot changes and osteomyelitis.
Staging/Classification
Modified Eichenholtz stages of Charcot arthropathy [5]
-
Clinical/prefragmentation stage:
-
Red, hot, swollen foot with significant inflammation
-
Often confused with cellulitis and infection
-
Minimal changes on x-rays
-
-
Dissolution/fragmentation stage:
-
Significant edema, warmth, erythema persists
-
Radiographs will show joint dislocation, bone fragmentation, and regional demineralization
-
-
Coalescence:
-
Erythema, edema, and inflammation decreased
-
Bone debris absorbed, new periosteal bone formation, and early healing seen on x-rays
-
-
Resolution:
-
Complete resolution of erythema, edema, and warmth
-
X-rays will show consolidation of healing with smooth bone edges and bony or fibrous ankyloses
-
Will likely have continued progression of deformity over time
-
Brodsky Anatomic Classification [1]
-
Type 1 – involves the midfoot
-
Most common, about 60% of Charcot joints
-
Usually requires shorter treatment duration for healing
-
Progresses to classic “rocker bottom” foot deformity
-
High risk of development of pressure ulcers and associated infection
-
-
Type 2 – involves the hindfoot joints: subtalar, talonavicular, calcaneocuboid
-
Significant instability but pressure sores and infection are less common
-
-
Type 3 – tibiotalar joint involvement
-
Least common
-
Significant deformity, instability, and disability
-
Usually require significant bracing and/or surgical treatment
-
Treatment
-
Goals are to preserve stability and alignment while the Charcot process evolves.
-
Initial treatment is total contact casting and protected weight bearing
-
Duration of casting depends on deformity and patient’s ability to comply with non-weight bearing
-
Transition to AFO, Arizona brace, or CROW boot once initial warmth and swelling resolves
-
Shoe modification to unload pressure from bony prominences
-
If non-operative treatment fails, surgical treatment is considered. Options include tendon Achilles lengthening, exostectomy, and fusion of affected joints
-
References
Ergen FB, Sanverdi SE, Oznur A. Charcot foot in diabetes and an update on imaging. Diabet Foot Ankle. 2013. doi: 10.3402/dfa.v4i0.21884. PubMed central PMCID: PMC3837304.
Johnson JE, Klein SE, Brodsky JW. Chapter 27: Diabetes. In: Coughlin MJ, Saltzman CL, Anderson RB, editors. Mann’s surgery of the foot and ankle – expert consult, vol. 2. 9th ed. Philadelphia: Elsevier; 2014. p. 1385–480.
Kadakia AR, Irwin TA. Chapter 6: disorders of the foot and ankle. In: Miller MD, Thompson SR, Hart JE, editors. Review of Orthopedics. 6th ed. Philadelphia: Elsevier; 2012. p. 488–90.
Milne TE,Rogers JR, Kinnear EM, Martin HV, Lazzarini PA, Quinton TR, Boyle FM. Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot Neuro-Arthropathy: a systematic review. J Foot Ankle Res. 2013;6:30. PubMed CMID PMCID: PMC3737070.
Rosenbaum AJ, DiPreta JA. Classifications in brief: eichenholz classification of charcot arthropathy. J Clin Ortho Relat Res. 2015;473(3):1168–71.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Severson, M.N., Johnson, M.D. (2017). Charcot Neuroarthropathy. In: Eltorai, A., Eberson, C., Daniels, A. (eds) Orthopedic Surgery Clerkship. Springer, Cham. https://doi.org/10.1007/978-3-319-52567-9_90
Download citation
DOI: https://doi.org/10.1007/978-3-319-52567-9_90
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52565-5
Online ISBN: 978-3-319-52567-9
eBook Packages: MedicineMedicine (R0)